Lower threshold for admission given frailty and limited reserves
Social factors: limited home support for prolonged oral antibiotic adherence
Nutrition support more critical in older catabolic patients
Pediatrics
Epidemiology differences in children
Less common than in adults; associated with complicated pneumonia
Primary abscess in healthy children often S. aureus (including MRSA) or Streptococcus milleri group
Secondary abscess associated with foreign body aspiration, congenital lung malformation, or immunodeficiency
Complicated pneumonia including lung abscess reviewed in Lancet 2020
Antibiotic therapy weight-based dosing
Ampicillin-sulbactam IV
50 mg/kg/dose of ampicillin component IV every 6 hours
Maximum 2 g ampicillin component per dose
Clindamycin IV
10-13 mg/kg/dose IV every 6-8 hours
Maximum 600 mg per dose
Amoxicillin-clavulanate PO for step-down
45 mg/kg/day of amoxicillin component divided every 12 hours
Maximum 875 mg amoxicillin component per dose
Vancomycin IV when MRSA suspected
15 mg/kg/dose IV every 6-8 hours
AUC/MIC monitoring in prolonged courses
Clinical differences
Higher rate of spontaneous drainage through bronchus in children
Better prognosis than adults, mortality low in immunocompetent children
Respiratory distress assessment age-appropriate
Feeding intolerance as severity marker in infants
Nasal flaring and subcostal retractions
Interventional approach
Conservative management with IV antibiotics first-line
Percutaneous drainage or surgical resection reserved for failure of medical therapy or complications
Pediatric surgery and pediatric pulmonology consultation for complex cases
Background
Epidemiology
Incidence and population
Annual incidence approximately 2-3 per 100,000 population in high-income countries
Predominantly affects middle-aged to older adults
Male predominance in most cohort data
Median age in Danish national cohort was in sixth decade
Mortality burden
1-month mortality approximately 2.7%
12-month all-cause mortality approximately 15.8%
ICU-level lung abscess mortality approximately 21.5%
High long-term mortality underscores severity and need for close follow-up
Risk factor prevalence in cohort data
COPD: 35% of patients
Immunocompromise: 41% of ICU patients
Diabetes mellitus: approximately 30%
Cancer: 20.5% of ICU cases
Alcohol use disorder: 20-22%
Poor dental hygiene: 42% where documented
Classification
Primary lung abscess: aspiration in patients with risk factors (alcoholism, poor dentition, impaired consciousness)
Secondary lung abscess: bronchial obstruction by tumor or foreign body, hematogenous spread from endocarditis or IVDU, extension from extrapulmonary infection
12% of ICU cases require bronchial artery embolization
Therapeutic Considerations
Antibiotic strategy principles
Prolonged therapy is the cornerstone of management
Median 38 days (IQR 30-51 days) in published cohort
Guided by clinical and radiographic response
Anaerobic coverage essential for community-acquired aspiration abscess
Clindamycin superior to penicillin in comparative randomized trials
Ampicillin-sulbactam provides combined aerobic and anaerobic coverage
Metronidazole monotherapy inferior and should be avoided
Failed in 5 of 11 patients in randomized trial vs clindamycin
Hospital-acquired abscesses require broader Gram-negative and MRSA coverage
Piperacillin-tazobactam or meropenem backbone
Drainage strategy
Over 80% resolve with antibiotics alone
Percutaneous catheter drainage for peripheral refractory abscesses: 83% resolution
Endoscopic drainage for central abscesses or coagulopathy
Surgical resection in approximately 13% of ICU cases
Modifiable risk factor management
Alcohol cessation counseling in 20-22% of cases
Dental care referral for periodontal disease (42% of patients)
Swallow evaluation and aspiration precautions
Smoking cessation
Glycemic control in diabetes to reduce empyema risk
Monitoring during prolonged therapy
CBC, CRP, renal function, and liver function periodically
Radiographic monitoring to guide duration
Watch for C. difficile colitis with prolonged antibiotics
Bronchoscopy if no resolution to exclude malignancy
Patient Discharge Instructions
copy discharge instructions
Lung abscess home care instructions
Take all antibiotics exactly as prescribed until the full course is complete
Do not stop early even if feeling better
Treatment typically lasts several weeks
Drink plenty of fluids to stay hydrated
Rest and limit strenuous activity until cleared by your doctor
Sleep with the head of the bed elevated
Aspiration prevention at home
Sit fully upright for all meals and snacks
Remain upright for at least 30 minutes after eating
Take small bites, eat slowly
Avoid alcohol and sedating medications
Maintain good oral hygiene including tooth brushing twice daily
Follow-up appointments
See your doctor or specialist within 1-2 weeks of discharge
Repeat chest imaging will be arranged at approximately 4-6 weeks
Attend all scheduled appointments as the infection requires close monitoring
If dental or gum disease is present, arrange dental review
Return to emergency department immediately if
Difficulty breathing at rest or worsening shortness of breath
Coughing up blood
Fever returning or worsening after initial improvement
Severe chest pain
Confusion or unusual drowsiness
Inability to swallow or take your antibiotic medications
Severe stomach pain or persistent diarrhea (risk of antibiotic-associated colitis)
References
Guidelines and key sources
Landmark studies and cohort data
Mandell LA, Niederman MS. Aspiration Pneumonia. New England Journal of Medicine. 2019. NEJM doi 10.1056/NEJMra1714562
Vaarst JK, Sperling S, Dahl VN, et al. Lung Abscess: Clinical Characteristics of 222 Danish Patients Diagnosed From 2016 to 2021. Respiratory Medicine. 2023. PMID 37302422
Montméat V, Bonny V, Urbina T, et al. Epidemiology and Clinical Patterns of Lung Abscesses in ICU: A French Multicenter Retrospective Study. Chest. 2023. PMID 37652296
Zhang R, Yu J, Shang X, et al. Heterogeneity in Clinical Patterns of Adult Lung Abscess Patients: An 8-Year Retrospective Study. BMC Pulmonary Medicine. 2025. PMID 40045326
Cai XD, Yang Y, Li J, et al. Logistic Regression Analysis of CT Features of Pulmonary Abscesses and Risk Factors for Empyema. Clinics. 2019. PMID 30994710
Batra K, Walker CM, Little BP, et al. ACR Appropriateness Criteria Acute Respiratory Illness in Immunocompetent Patients: 2024 Update. JACR. 2025
Stark DD, Federle MP, Goodman PC, et al. Differentiating Lung Abscess and Empyema: Radiography and CT. AJR. 1983. PMID 6602513
Hadid W, Stella GM, Maskey AP, et al. Lung Abscess: The Non-Conservative Management: A Narrative Review. Journal of Thoracic Disease. 2024. PMID 38883669
Microbiology and treatment references
Hammond JM, Potgieter PD, Hanslo D, et al. Etiology and Antimicrobial Susceptibility in Acute Community-Acquired Lung Abscess. Chest. 1995. PMID 7555164
Gafoor K, Patel S, Girvin F, et al. Cavitary Lung Diseases: A Clinical-Radiologic Algorithmic Approach. Chest. 2018. PMID 29518379
Sperling S, Dahl VN, Fløe A. Lung Abscess: An Update on Current Knowledge. Current Opinion in Pulmonary Medicine. 2024. PMID 38411181
de Benedictis FM, Kerem E, Chang AB, et al. Complicated Pneumonia in Children. Lancet. 2020. PMID 32919518
Alshadfan L, Abualhaj S, Kilani M, et al. Clinical Presentation and Management Outcomes of Pediatric Lung Abscess. PLoS One. 2025. PMID 41886424
ICD-10 coding
ICD-10 J85.0 Gangrene and necrosis of lung
ICD-10 J85.1 Abscess of lung with pneumonia
ICD-10 J85.2 Abscess of lung without pneumonia
ICD-10 J86.9 Pyothorax without fistula (empyema)
SNOMED CT 44621007 Abscess of lung
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.